Division of Pulmonary Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813779, Taiwan.
School of Medicine, National Yang-Ming University, Taipei 112304, Taiwan.
Int J Environ Res Public Health. 2021 Apr 1;18(7):3682. doi: 10.3390/ijerph18073682.
Patients with influenza infection may develop acute respiratory distress syndrome (ARDS), which is associated with high mortality. Some patients with ARDS receiving extracorporeal membrane oxygenation (ECMO) support die of infectious complications. We aimed to investigate the risk factors affecting the clinical outcomes in critically ill patients with influenza. We retrospectively reviewed the medical records of influenza patients between January 2006 and May 2016 at the Kaohsiung Veterans General Hospital in Taiwan. Patients aged below 20 years or without laboratory-confirmed influenza were excluded. Critically ill patients who presented with ARDS ( = 0.004, odds ratio (OR): 8.054, 95% confidence interval (CI): 1.975-32.855), a higher Acute Physiology and Chronic Health Evaluation (APACHE) II score ( = 0.008, OR: 1.102, 95% CI: 1.025-1.184), or higher positive end-expiratory pressure ( = 0.008, OR: 1.259, 95% CI: 1.061-1.493) may have a higher risk of receiving ECMO. Influenza A ( = 0.037, OR: 0.105, 95% CI: 0.013-0.876) and multiple organ failure ( = 0.007, OR: 0.056, 95% CI: 0.007-0.457) were significantly associated with higher mortality rates. In conclusion, our study showed critically ill influenza patients with ARDS, higher APACHE II scores, and higher positive end-expiratory pressure have a higher risk of receiving ECMO support. Influenza A and multiple organ failure are predictors of mortality.
患者流感感染可能发展为急性呼吸窘迫综合征(ARDS),这与高死亡率相关。一些接受体外膜氧合(ECMO)支持的 ARDS 患者死于感染并发症。我们旨在研究影响流感重症患者临床结果的危险因素。我们回顾性审查了台湾高雄荣民总医院 2006 年 1 月至 2016 年 5 月期间流感患者的病历。排除年龄低于 20 岁或无实验室确诊流感的患者。患有 ARDS 的危重症流感患者(=0.004,比值比(OR):8.054,95%置信区间(CI):1.975-32.855)、更高的急性生理学和慢性健康评估(APACHE)II 评分(=0.008,OR:1.102,95%CI:1.025-1.184)或更高的呼气末正压(=0.008,OR:1.259,95%CI:1.061-1.493)可能有更高的 ECMO 治疗风险。甲型流感(=0.037,OR:0.105,95%CI:0.013-0.876)和多器官衰竭(=0.007,OR:0.056,95%CI:0.007-0.457)与更高的死亡率显著相关。总之,我们的研究表明,患有 ARDS、更高的 APACHE II 评分和更高的呼气末正压的危重症流感患者有更高的接受 ECMO 支持的风险。甲型流感和多器官衰竭是死亡的预测因素。